financetom
Business
financetom
/
Business
/
AbbVie to buy Gilgamesh Pharmaceuticals' depression drug for up to $1.2 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AbbVie to buy Gilgamesh Pharmaceuticals' depression drug for up to $1.2 billion
Aug 25, 2025 6:37 AM

Aug 25 - Drugmaker AbbVie said on Monday it

would buy privately held Gilgamesh Pharmaceuticals' treatment

for major depressive disorder in a deal worth up to $1.2

billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved